Nagaraj Manickam (N Manickam)

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 3

Top Topics

Low Density Lipoprotein

Biofilm Formation

Pseudomonas Aeruginosa

Top Venues

Journal of cellular biochemistry

Journal of endocrinological investigation

Journal of lipid and atherosclerosis

This page only lists publications with an associated author ORCID identifier.

Publications

Saravanakumar Sundararajan, Isaivani Jayachandran, Gautam Kumar Pandey, Saravanakumar Venkatesan, Anusha Rajagopal, Kuppan Gokulakrishnan, Muthuswamy Balasubramanyam, Viswanathan Mohan, Nagaraj Manickam
Metformin Reduces the Progression of Atherogenesis by Regulating the Sestrin2-mTOR Pathway in Obese and Diabetic Rats. Journal of lipid and atherosclerosis 12 (3) (2023)
S Sundararajan, I Jayachandran, S C Subramanian, R M Anjana, M Balasubramanyam, V Mohan, B Venkatesan, Nagaraj Manickam
Decreased Sestrin levels in patients with type 2 diabetes and dyslipidemia and their association with the severity of atherogenic index. Journal of endocrinological investigation 44 (7) (2020)
Saravanakumar Sundararajan, Isaivani Jayachandran, Muthuswamy Balasubramanyam, Viswanathan Mohan, Balachandar Venkatesan, Nagaraj Manickam
Sestrin2 regulates monocyte activation through AMPK-mTOR nexus under high-glucose and dyslipidemic conditions. Journal of cellular biochemistry (2018)